• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 LINE-ePRO 系统从乳腺癌患者收集患者报告结局的可行性研究。

Feasibility study on collecting patient-reported outcomes from breast cancer patients using the LINE-ePRO system.

机构信息

Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.

出版信息

Cancer Sci. 2022 May;113(5):1722-1730. doi: 10.1111/cas.15329. Epub 2022 Mar 26.

DOI:10.1111/cas.15329
PMID:35279907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9128183/
Abstract

Due to the increasing complexity of cancer treatment, ensuring safety and maintaining the quality of life during treatment are important issues. Patient-reported outcomes (PROs) in oncology are essential for assessing patient symptoms. A feasibility study was undertaken on breast cancer patients by building a PRO data collection system based on LINE, one of the most popular social network service applications in Japan. In this study, one or more predefined PRO questions for each breast cancer patient's clinical situation were sent to the patient's LINE application daily. The patient selected a predefined answer by tapping the screen, but no free-text answers were allowed. Seventy-three patients were enrolled. The median observation period was 435 days (84-656 days), and the total number of PROs collected was 16,417, with a mean of 224.9 reports per patient. Patients on adjuvant endocrine therapy were notified of 2.5 questions per week, and the median number of responses per week and response rate were 2.387 (1.687-11.627) and 95.5%, respectively. Analyzing the results by age group, the number of responses from those aged 60 and above was equal to or higher than that of the younger age group. It was also possible to track each patient's PROs accurately. These results suggested that the design of the system, based on an application used daily, instead of using specifically prepared applications for collecting electronic PROs, was the reason for the favorable acceptance from patients and the satisfactory response rate from all age groups, including the elderly.

摘要

由于癌症治疗的日益复杂性,确保治疗期间的安全性和维持生活质量是重要问题。肿瘤患者报告的结局(PROs)对于评估患者症状至关重要。本研究通过基于日本最受欢迎的社交网络服务应用程序之一 LINE 构建 PRO 数据采集系统,对乳腺癌患者进行了可行性研究。在这项研究中,每天向每位乳腺癌患者的 LINE 应用程序发送一个或多个针对其临床情况的预设 PRO 问题。患者通过点击屏幕选择预设答案,但不允许输入自由文本答案。共纳入 73 例患者。中位观察期为 435 天(84-656 天),共采集了 16417 份 PRO,每位患者的平均报告数为 224.9 份。接受辅助内分泌治疗的患者每周收到 2.5 个问题通知,每周的平均回复数和回复率分别为 2.387(1.687-11.627)和 95.5%。按年龄组分析结果,60 岁及以上患者的回复数量与年轻患者组相当或更高。此外,还可以准确跟踪每位患者的 PROs。这些结果表明,该系统的设计基于日常使用的应用程序,而不是使用专门用于收集电子 PROs 的应用程序,这是患者接受度良好和所有年龄段(包括老年人)均有满意回复率的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/110de0d7d4c1/CAS-113-1722-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/509a392b89a4/CAS-113-1722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/50715ec07f1e/CAS-113-1722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/8093b5818336/CAS-113-1722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/7bc4be489bc3/CAS-113-1722-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/110de0d7d4c1/CAS-113-1722-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/509a392b89a4/CAS-113-1722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/50715ec07f1e/CAS-113-1722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/8093b5818336/CAS-113-1722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/7bc4be489bc3/CAS-113-1722-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732e/9128183/110de0d7d4c1/CAS-113-1722-g006.jpg

相似文献

1
Feasibility study on collecting patient-reported outcomes from breast cancer patients using the LINE-ePRO system.使用 LINE-ePRO 系统从乳腺癌患者收集患者报告结局的可行性研究。
Cancer Sci. 2022 May;113(5):1722-1730. doi: 10.1111/cas.15329. Epub 2022 Mar 26.
2
PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer.PROutine:一项评估通过智能手机应用程序对晚期癌症患者的电子患者报告结局及依从性进行监测的可行性研究。
Ann Palliat Med. 2019 Apr;8(2):104-111. doi: 10.21037/apm.2017.07.05. Epub 2017 Oct 26.
3
Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.患者报告结局(PRO)聚焦于辅助性和转移性乳腺癌中的不良事件(PRO-AE):临床及转化意义
Support Care Cancer. 2017 Feb;25(2):549-558. doi: 10.1007/s00520-016-3437-2. Epub 2016 Oct 17.
4
Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy.电子患者报告结局在乳腺癌辅助放疗期间的应用。
Clin Breast Cancer. 2021 Jun;21(3):e252-e270. doi: 10.1016/j.clbc.2020.10.004. Epub 2020 Oct 20.
5
Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy - a feasibility study.电子报告在癌症治疗期间脆弱且合并症较多的患者中的患者报告结局 - 一项可行性研究。
Health Qual Life Outcomes. 2020 Jul 11;18(1):225. doi: 10.1186/s12955-020-01480-3.
6
An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study.一种用于测量乳腺癌患者健康相关生活质量的FACT-B(癌症治疗功能评估-乳腺癌)问卷的电子患者报告结局工具:可靠性研究
J Med Internet Res. 2019 Jan 22;21(1):e10004. doi: 10.2196/10004.
7
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial.电子患者报告结局应用程序在乳腺癌患者健康相关生活质量中的实施:在一项两中心前瞻性试验中的评估和可接受性分析。
J Med Internet Res. 2022 Feb 8;24(2):e16128. doi: 10.2196/16128.
8
Integrating patient reported outcomes with clinical cancer registry data: a feasibility study of the electronic Patient-Reported Outcomes From Cancer Survivors (ePOCS) system.将患者报告结局与临床癌症登记数据相结合:癌症幸存者电子患者报告结局(ePOCS)系统的可行性研究。
J Med Internet Res. 2013 Oct 25;15(10):e230. doi: 10.2196/jmir.2764.
9
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.关于支持电子和纸质患者报告结局(PRO)测量等效性所需证据的建议:国际药物经济学与结果研究协会(ISPOR)电子PRO良好研究实践工作组报告
Value Health. 2009 Jun;12(4):419-29. doi: 10.1111/j.1524-4733.2008.00470.x. Epub 2008 Nov 11.
10
eHealth System for Collecting and Utilizing Patient Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care) Among Cancer Patients: Mixed Methods Approach to Evaluate Feasibility and Acceptability.癌症患者中用于个性化治疗和护理的患者报告结局测量收集与利用电子健康系统(PROMPT-Care):评估可行性和可接受性的混合方法
J Med Internet Res. 2017 Oct 2;19(10):e330. doi: 10.2196/jmir.8360.

引用本文的文献

1
Demographic and clinical impact on preoperative BREAST-Q ePROM completion and baseline outcomes in women undergoing breast cancer surgery: a quantitative descriptive study at a Danish university hospital.乳腺癌手术女性术前BREAST-Q电子患者报告结局量表完成情况及基线结果的人口统计学和临床影响:丹麦一家大学医院的定量描述性研究
BMJ Open. 2025 Jan 2;15(1):e091122. doi: 10.1136/bmjopen-2024-091122.
2
Monitoring health as an opportunity to categorize preventative and early-treatment actions in a self-care journey: our experience with a Healthcare Magenta Scorecard.将健康监测作为在自我保健过程中对预防和早期治疗行动进行分类的契机:我们使用医疗保健品红色记分卡的经验。
Mhealth. 2023 Apr 24;9:25. doi: 10.21037/mhealth-22-56. eCollection 2023.
3

本文引用的文献

1
The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women.老年女性身体健康相关生活质量、身体机能与对侧乳腺癌风险之间的关系。
Breast Cancer. 2022 Mar;29(2):287-295. doi: 10.1007/s12282-021-01309-x. Epub 2021 Nov 19.
2
Web-Based Patient-Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care): Multicenter Pragmatic Nonrandomized Trial.基于网络的患者报告结局测量用于个性化治疗和护理(PROMPT-Care):多中心实用非随机试验。
J Med Internet Res. 2020 Oct 29;22(10):e19685. doi: 10.2196/19685.
3
Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study.
Electronic patient-reported outcome measures to enable systematic follow-up in treatment and care of women diagnosed with breast cancer: a feasibility study protocol.
电子患者报告结局测量在女性乳腺癌诊治和照护中进行系统随访的可行性研究方案。
BMJ Open. 2022 Nov 16;12(11):e065110. doi: 10.1136/bmjopen-2022-065110.
使用电子患者报告结局工具(KISS)对接受抗PD-(L)1治疗的癌症患者进行随访:前瞻性可行性队列研究
JMIR Form Res. 2020 Oct 28;4(10):e17898. doi: 10.2196/17898.
4
Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy - a feasibility study.电子报告在癌症治疗期间脆弱且合并症较多的患者中的患者报告结局 - 一项可行性研究。
Health Qual Life Outcomes. 2020 Jul 11;18(1):225. doi: 10.1186/s12955-020-01480-3.
5
Utilizing Digital Health to Collect Electronic Patient-Reported Outcomes in Prostate Cancer: Single-Arm Pilot Trial.利用数字健康收集前列腺癌患者自我报告的电子结局:单臂试点试验。
J Med Internet Res. 2020 Mar 25;22(3):e12689. doi: 10.2196/12689.
6
Collection of electronic patient-reported symptoms in patients with advanced cancer using Epic MyChart surveys.使用 Epic MyChart 调查收集晚期癌症患者的电子患者报告症状。
Support Care Cancer. 2020 Jul;28(7):3153-3163. doi: 10.1007/s00520-019-05109-0. Epub 2019 Nov 8.
7
An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study.一种用于测量乳腺癌患者健康相关生活质量的FACT-B(癌症治疗功能评估-乳腺癌)问卷的电子患者报告结局工具:可靠性研究
J Med Internet Res. 2019 Jan 22;21(1):e10004. doi: 10.2196/10004.
8
Recent Improvement in the Long-term Survival of Breast Cancer Patients by Age and Stage in Japan.日本乳腺癌患者年龄和分期的长期生存率的近期改善。
J Epidemiol. 2018 Oct 5;28(10):420-427. doi: 10.2188/jea.JE20170103. Epub 2018 Feb 24.
9
Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.欧洲癌症研究与治疗组织核心问卷(EORTC QLQ-C30)电子患者报告结局(e-PRO)工具用于测量乳腺癌患者健康相关生活质量的可靠性:前瞻性随机试验
J Med Internet Res. 2017 Sep 14;19(9):e322. doi: 10.2196/jmir.8210.
10
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.一项评估常规癌症治疗期间症状监测的患者报告结局的试验的总生存结果。
JAMA. 2017 Jul 11;318(2):197-198. doi: 10.1001/jama.2017.7156.